Ross Camidge MD PhD of the University of Colorado Cancer Center discusses how the COVID-19 pandemic has influenced rare cancer patients. Dr. Camidge is a doctor who typically works with patients with metastatic non-small cell lung cancer (NSCLC), a rare form of lung cancer. However, as Dr. Camidge mentions, the contingency plans for his nearby hospital required specialists like himself to be prepared to help other specialist teams if needed.

In terms of how the pandemic is affecting cancer patients, Dr. Camidge mentions that some patients may be hesitant to receive treatment in the hospital but he asserts that it is important to continue cancer treatment because “COVID is serious; lung cancer is more serious.”

свернуть